Industry Odisha Bureau, Oct 18: FSSAI has proposed residue limits for acetamiprid and imidacloprid in tea. The draft caps them…
Browsing: Health
Industry Odisha Bureau, Oct 15: Biocon’s global settlement with Genentech clears patent hurdles for Pebrilzo, its pertuzumab biosimilar. Launch windows…
Industry Odisha Bureau, Oct 14: The Centre wants hospitals and clinics to display service rates clearly for patients. The request…
Industry Odisha Bureau, Oct 13: An expert panel is to finalise the list of covered cancer drugs by 14 October.…
Industry Odisha Bureau, Oct 11: India has alerted its national laboratory network and checked antibiotic reserves. Officials say the risk…
Industry Odisha Bureau, Oct 10: Retailers, wholesalers and distributors could need central approval to advertise prescription drugs. Manufacturers already face…
Industry Odisha Bureau, Oct 08: Western buyers are spreading pharmaceutical orders beyond China, and some Indian firms are benefiting. Drug…
Industry Odisha Bureau, Oct 05: India’s drugmakers built global scale by supplying generic medicines. Industry leaders now want that scale…
Industry Odisha Bureau, Oct 04: FSSAI classified a tested sample of Nestle India’s low-fat dairy whitener as unsafe and substandard.…
Industry Odisha Bureau, Sept 30: India has extended minimum import prices on two pharmaceutical raw materials, ATS-8 and Sulfadiazine API.…